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Haemophilus parasuis, the causative agent of Glässer’s disease, is one of the early colonizers of the nasal mucosa of piglets. It is
prevalent in swine herds, and lesions associated with disease are fibrinous polyserositis and bronchopneumonia. Antibiotics are
commonly used in disease control, and resistance to several antibiotics has been described in H. parasuis. Prediction of H. para-
suis virulence is currently limited by our scarce understanding of its pathogenicity. Some genes have been associated with H.
parasuis virulence, such as lsgB and group 1 vtaA, while biofilm growth has been associated with nonvirulent strains. In this
study, 86 H. parasuis nasal isolates from farms that had not had a case of disease for more than 10 years were obtained by sam-
pling piglets at weaning. Isolates were studied by enterobacterial repetitive intergenic consensus PCR and determination of the
presence of lsgB and group 1 vtaA, biofilm formation, inflammatory cell response, and resistance to antibiotics. As part of the
diversity encountered, a novel 2,661-bp plasmid, named pJMA-1, bearing the blaROB-1-lactamase was detected in eight coloniz-
ing strains. pJMA-1 was shown to share a backbone with other small plasmids described in the Pasteurellaceae, to be 100% sta-
ble, and to have a lower biological cost than the previously described plasmid pB1000. pJMA-1 was also found in nine H. para-
suis nasal strains from a separate collection, but it was not detected in isolates from the lesions of animals with Glässer’s disease
or in nontypeable Haemophilus influenzae isolates. Altogether, we show that commensal H. parasuis isolates represent a reser-
voir of-lactam resistance genes which can be transferred to pathogens or other bacteria.
Haemophilus parasuis is an early colonizer and amember of thenormalmicrobiota of the upper respiratory tract of piglets.H.
parasuis initial acquisition occurs through direct contact with the
sow after birth, and the bacterium establishes colonization in the
upper respiratory tract, with a maximum level of colonization
occurring at about 2 months of age (1). Under certain circum-
stances, some strains spread to the lungs to cause pneumonia or
invade systemic sites. Systemic invasion produces fibrinous poly-
serositis and arthritis, which are the characteristic lesions of Gläss-
er’s disease (2, 3).
AlthoughH. parasuis is an important swine pathogen, its host-
pathogen interactions remain to be well understood. DifferentH.
parasuis strains can be isolated from the nasal cavity of a given
animal, and these nasal strains are not particularly stable, since
they experience turnover during the life of the pigs (1, 4–6).
Strains ofH. parasuis are heterogeneous and include virulent and
nonvirulent strains. It is common to find nonvirulent strains in
the upper respiratory tract of healthy animals, but virulent strains
can also be found (6). Different methods have been developed to
differentiate H. parasuis strains. Genotyping methods include
multilocus sequence typing (MLST) (7, 8), partial sequence of the
60-kDa heat shock protein-encoding gene hsp60 (9), enterobacte-
rial repetitive intergenic consensus PCR (ERIC-PCR) (10), or
pulsed-field gel electrophoresis (11). A search for genetic markers
to identify putative virulent H. parasuis isolates revealed the po-
tential of the virulence-associated trimeric autotransporter-en-
coding (vtaA) genes to be a diagnostic tool (12) and suggested an
association of the lsgB gene, which encodes a sialyltransferase in-
volved in the sialylation of the lipooligosaccharide (LOS) mole-
cule, with virulent strains (13). A number of other bacterial factors
have been associatedwithH. parasuis virulence, including 6-phos-
phogluconate dehydrogenase (14), a complete LOS molecule
(15), cytolethal distending toxin (16, 17), immunoglobulin A pro-
tease (18), capsule (19), and the outer membrane protein OmpP2
(20–22).
Serovar diversity and the high number of nonserotypeable iso-
lates that have been reported have negatively affected the develop-
ment of effective cross-protective vaccines, due to limited cross
protection among H. parasuis strains (23). Since no definite vac-
cine is available, antimicrobial treatment continues to be the strat-
egy used to control the disease. Tetracyclines are the major anti-
microbials used against this bacterium, but resistance has been
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found in many instances (24–26), suggesting the need for more
effective molecules to treat infected animals (27). Penicillins and
aminopenicillins are being used as alternative treatments for in-
fections due to H. parasuis. Of note, clinical isolates resistant to
-lactams have been found in large numbers in several countries
(26, 27), and biofilm formation by H. parasuis strains may have a
positive correlation with resistance to -lactam antibiotics (28).
-Lactam resistance in H. parasuis clinical strains isolated from
Glässer’s disease lesions has been related to plasmid pB1000,
which bears the ROB-1 -lactamase, belongs to the ColE1 super-
family, is mobilized into Escherichia coli using the conjugation
machinery of an IncP plasmid, and has also been found in Pasteu-
rella multocida and Haemophilus influenzae clinical isolates (11,
29, 30).However, antibiotic resistance in the colonizer population
ofH. parasuis has not been previously examined, and its potential
as a reservoir of antibiotic resistance genes has not been explored.
Here, we describe the novel small plasmid pJMA-1, which was
isolated from strains of H. parasuis found in the nasal cavities of
healthy animals and which carries ROB-1-mediated -lactam re-
sistance. pJMA-1 sequence features and its relationship with pre-
viously describedmobile elements, functionality, transmissibility,
and stability were analyzed. The implications of antibiotic resis-
tance carried by a plasmid in H. parasuis nasal strains are further
discussed.
MATERIALS AND METHODS
Bacterial strains and culture conditions. H. parasuis strains were grown
overnight at 37°C with 5% CO2 on chocolate agar plates (bioMérieux,
France). TheH. parasuis strains belonged to three isolate collections: (i) 86
strains isolated from nasal swabs taken from healthy pigs at weaning in
Navarra, Spain (generated in this study), (ii) 20 strains isolated fromnasal
swab samples taken from healthy pigs at weaning in Catalonia and Ma-
llorca, Spain (8, 9, 31), and (iii) 24 strains isolated from Glässer’s disease
lesions (8, 9, 31). H. parasuis Nagasaki (virulent), SW114 (nonvirulent),
BB1033 (10), and BB1023 (10) were used as reference strains, when nec-
essary.
Nontypeable (NT) Haemophilus influenzae strains were grown over-
night at 37°C with 5% CO2 on chocolate agar plates or on brain heart
infusion (BHI) agar plates supplemented with 10 g/ml hemin and 10
g/ml -NAD, referred to as sBHI agar. We employed 20 NT H. influen-
zae isolates recovered from the nasopharynges of healthy children in day
care centers and schools in Oviedo, Spain (32), 16 pediatric ear isolates
(Hospital Universitario Germans Trias i Pujol [HUGTiP], Badalona,
Spain) (this study), and 41 respiratory strains from pulmonary patients
(HUGTiP and Hospital Universitario Bellvitge, Barcelona, Spain) (this
study). H. influenzae Rd KW20 (33) was used as a reference strain for
plasmid transmissibility and stability analysis.When necessary, sBHI agar
containing ampicillin (AMP) at 25 g/ml was used.
Isolation of H. parasuis strains from nasal swab samples from
healthy piglets. From April to September 2012, nasal swab samples were
taken at weaning (3 to 4 weeks of age) from healthy pigs on six farrow-to-
finish farms and two farrow-to-weaning farms that had not had a case of
Glässer’s disease since 2000. The farms were located in an area of 9,500
km2 in Navarra, northern Spain. The farms were included on the basis of
the veterinarians’ knowledge of the farm and were selected because of
their different patterns regarding the respiratory health status of the pigs
and because they used the most common herd health patterns, housing
practices, and herd management practices encountered in the field at the
time. The sampling procedure was part of a periodic veterinarian farm
surveillance routine. The number of sows, production type, and weaning
age for each farmare summarized inTable 1. The nares of four animals per
farm were sampled. Swab (Deltalab, Spain) specimens from the nasal
cavities of all piglets were placed in Amies transport medium and kept on
ice until inoculation on chocolate agar plates. The plates were incubated at
37°C with 5% CO2, and suspect colonies of H. parasuis were selected and
subcultured on chocolate agar and blood agar (bioMérieux) plates. Col-
onies growing on chocolate agar but not on blood agar were identified by
conventional biochemicalmethods, bymass spectrometry using amatrix-
assisted laser desorption ionization biotyper (version 3.0; Bruker), and by
colony PCR based on species-specific amplification of the 16S RNA gene
with primers HPS-F and HPS-R (Table 2), rendering an 821-bp product
(34). For species-specific PCR, crude DNA templates derived directly
from colonies on agar were prepared by harvesting a loopful of bacteria
from a culture that had been grown overnight on a chocolate agar plate
and placing it into 0.5 ml of sterile water of the purity required for DNA
analysis; Tween 20 was added to a final concentration of 0.5%, and three
cycles of boiling (for 5 min) and cooling on ice (for 2 min) were per-
formed. The samples were centrifuged for 10 s at 15,000 g and imme-
diately placed on ice. An aliquot of 1l of the supernatant was used in the
PCR. When a nasal swab sample rendered a positive H. parasuis identifi-
cation, independent colonies from each swab (i.e., per animal) were sep-
arately tested and, if positive, stored in tryptic soy broth–20% glycerol at
80°C.
Molecular typing by ERIC-PCR. Crude DNAwas prepared following
the protocol described above and quantified. In each case, 100 ngwas used
as the template for ERIC-PCRwith primers ERIC1R and ERIC2 (Table 2).
We followed a previously published protocol (10) and included an extra
final extension step of 20 min. PCR products were analyzed by electro-
phoresis (70 V, 3 h) in a 2% agarose gel. Band patterns were visualized by
staining with ethidium bromide, and comparison of the patterns was per-
formed visually.
Serotyping. Serotype determination was performed by indirect hem-
agglutination at the Animal Health Department of the Veterinary School
at the University of León (León, Spain) following a previously published
protocol (35). Soluble antigen was obtained after boiling of a bacterial
suspension and subsequent centrifugation to eliminate insoluble debris.
Detection of the lsgB and group 1 vtaA genes. Crude DNA templates
derived directly from colonies on agar were prepared as described above.
The lsgB gene was PCR amplified using Taq polymerase (Biotools, Spain)
and the four primer pairs lsgB-F1 and lsgB-R1, lsgB-F1 and lsgB-R2-2,
lsgB-F2-2 and lsgB-R1, and lsgB-F2-2 and lsgB-R2-2 (Table 2). The vtaA
translocator domains from groups 1 and 3 were amplified in a multiplex
format following a previously published protocol (12). Multiplex PCR
tubes contained GoTaq buffer, which consisted of 2 mMMgCl2, 0.4 mM
each deoxynucleoside triphosphate dNTP, 800 nM primers YADAF1 and
PADHR1 (each), 400 nM primers YADAF3 and PADHR3 (each), 1 U
GoTaq polymerase (Promega, USA) and 10 ng genomic DNA in a final
volume of 25 l. Cycling conditions were 5 min at 94°C, followed by 25
cycles of 45 s at 94°C, 45 s at 64°C, and 1 min at 72°C, and then a final
incubation was carried out at 72°C for 7 min. In all cases, the virulent
reference strainH. parasuisNagasaki and the nonvirulent reference strain
H. parasuis SW114 were used as controls. PCR for vtaA group 3 (with
primers YADAF3 and PADHR3), previously shown to be present in allH.
parasuis strains (12), was used as a control.
Plasmid analysis of -lactam-resistant strains. Plasmid DNA was
extracted from bacteria grown on chocolate agar plates with a QIAprep
spin miniprep kit (Qiagen, Germany). PCRs were performed using Taq
polymerase (Biotools) with crude DNA (see above) or the extracted plas-
mid as the template. Identification of plasmids bearing blaROB-1 in -lac-
tam-resistant H. parasuis strains (strains for which the MICs of -lactam
antibiotics were elevated) was performed using primers rob-1F and rob-
1R, rendering a 457-bp amplicon, and with divergent blaROB-1 primers
rob-1D and rob-1U, which rendered a 2,238-bp or a 4,189-bp amplicon,
depending on the strain (Table 2). Purification of the PCR amplicons was
performed using aNucleoSpin gel and PCR cleanup kit (Macherey-Nagel,
Germany). Plasmid pJMA-1 was Sanger sequenced by PCR walking with
primers pl-SEQ-rob-1F, rob-1D, pB1000-F1, plSeqF2, plSeqF3, rob-1F,
rob-1R, and pl-SEQ-rob-1R (Table 2). Plasmid pB1000 was Sanger se-
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TABLE 1 Farm, number of sows, type of production, piglet weaning age, animal sampled, isolates, ERIC-PCR profiles, and genetic features of H.
parasuis isolates collected in this study
Farm
No. of
sows
Production type/weaning
age (days) Animal
H. parasuis
isolate
ERIC-PCR
profile
Presence of the following:
lsgB vtaA1 blaROB-1
blaROB-1-containing
plasmid (plasmid size
[kb])
A 250 Farrow to finish/28 A1 A1.1 NA-1    
A1 A1.2 NA-2    
A1 A1.3 NA-1    
A2 A2.1 NA-1    
A2 A2.2 NA-1    
A2 A2.3 NA-1    
A3 A3.1 NA-7     (2.6)
A3 A3.2 NA-7     (2.6)
A3 A3.3 NA-7     (2.6)
A4 A4.1 NA-10    
A4 A4.2 NA-10    
A4 A4.3 NA-10    
B 475 Farrow to weaning/21 B1 B1.1 NA-2    
B1 B1.2 NA-2    
B1 B1.3 NA-15    
B2 B2.1 NA-16    
B2 B2.2 NA-17    
B2 B2.3 NA-18    
B3 B3.1 NA-17    
B3 B3.2 NA-21    
B3 B3.3 NA-21    
B4 B4.1 NA-21    
B4 B4.2 NA-21    
B4 B4.3 NA-21    
C 95 Farrow to finish/28 C1 C1.1 NA-25    
C1 C1.3 NA-27    
C2 C2.1 NA-27    
C2 C2.2 NA-29    
C2 C2.3 NA-29    
C3 C3.1 NA-29    
C3 C3.2 NA-29    
C3 C3.3 NA-29    
C4 C4.1 NA-29    
C4 C4.2 NA-29    
C4 C4.3 NA-29    
D 180 Farrow to finish/28 D1 D1.1 NA-37    
D1 D1.2 NA-37    
D1 D1.3 NA-39    
D2 D2.1 NA-40    
D2 D2.2 NA-41    
D3 D3.1 NA-37    
D3 D3.2 NA-37    
D3 D3.3 NA-37    
D4 D4.1 NA-46     (2.6)
D4 D4.2 NA-46     (2.6)
D4 D4.3 NA-48     (4.6)
E 500 Farrow to finish/28 E1 E1.1 NA-67    
E1 E1.2 NA-67    
E1 E1.3 NA-67    
E2 E2.1 NA-52    
E2 E2.2 NA-52    
E2 E2.3 NA-54    
E3a
E4a
(Continued on following page)
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quenced by PCR walking with primers rob-1D, rob-1U, plSeqF3, Pl298-
SEQ-rob-1F, Pl298-SEQ-F, Pl298-SEQ-R, Pl298-SEQ2-F, and Pl157-
SEQ-R (Table 2).
Antimicrobial susceptibility testing. In vitro antimicrobial suscepti-
bility was determined by microdilution methods following Clinical and
Laboratory Standards Institute (CLSI) guidelines (36, 37) and the meth-
ods described in previous studies (11, 29). Briefly, bacterial inocula were
prepared from colonies freshly grown for 24 h on chocolate agar plates,
and the inoculum was adjusted to a 0.5 McFarland standard in haemo-
philus test medium (HTM; Becton Dickinson, USA); 50 l of each bacte-
rial suspension was used per well. The antimicrobials used for microdilu-
tion were AMP and amoxicillin (AMX). Stock solutions were prepared
from the pure powder form according to the CLSI standard method (36,
37), and the antimicrobials were used over a concentration range from 1
to 2,048g/ml. Alternatively, we used commercially available dehydrated
Sensititre plate panels (EUMVS2; Trek Diagnostics Inc., USA) for cefo-
taxime (CTX), ceftazidime (CAZ), sulfamethoxazole (SXT), gentamicin
(GEN), ciprofloxacin (CIP), tetracycline (TET), streptomycin (STR), tri-
methoprim (TMP), chloramphenicol (CHL), colistin (CST), florfenicol
(FFN), kanamycin (KAN), and nalidixic acid (NAL). For both the mi-
crodilution and Sensititre assays, panel quality controls were performed
with strains H. parasuis BB1023 (-lactam resistant) and BB1033 (-lac-
tam sensitive) (11). The MIC was defined as the lowest antimicrobial
concentration that inhibited bacterial growth. Given that a standard tech-
nique for determination of the antimicrobial susceptibility of H. parasuis
and agreed-upon interpretation criteria do not currently exist (38), the
MIC results were reviewed and the distribution of strains over the MIC
range was considered.
Biofilm formation. H. parasuis strains were grown on chocolate agar
plates for 16 h at 37°C in 5%CO2. Four to five freshly grown colonies were
used to inoculate 10 ml BHI with 10 g/ml -NAD and grown at 37°C
with 5% CO2 to an optical density at 600 nm (OD600) of 0.7. Ten mi-
croliters of the grown culture was diluted in 100 l sBHI on 96-well
polystyrene plates (Iwaki, Japan); alternatively, 100 l of the grown cul-
ture was diluted in 586 l sBHI on 24-well polystyrene plates (Costar;
Corning, USA). The plates were incubated statically for 36 h at 37°C in 5%
CO2. The culture medium was then carefully removed, the plates were
washed in distilled water, and the attached bacteria were fixed for 15 min
with 100 l (96-well plates) or 586 l (24-well plates) methanol. The
methanol was removed, and the plates were air dried for 15min. Once the
TABLE 1 (Continued)
Farm
No. of
sows
Production type/weaning
age (days) Animal
H. parasuis
isolate
ERIC-PCR
profile
Presence of the following:
lsgB vtaA1 blaROB-1
blaROB-1-containing
plasmid (plasmid size
[kb])
F 260 Farrow to finish/28 F1 F1.1 NA-29    
F1 F1.2 NA-29    
F1 F1.3 NA-29    
F2 F2.1 NA-29    
F2 F2.2 NA-29    
F2 F2.3 NA-29    
F3 F3.1 NA-2    
F3 F3.2 NA-2    
F3 F3.3 NA-2    
F4 F4.1 NA-64     (2.6)
F4 F4.2 NA-64     (2.6)
F4 F4.3 NA-64     (2.6)
G 160 Farrow to finish/21 G1 G1.1 NA-67    
G1 G1.2 NA-67    
G1 G1.3 NA-67    
G2 G2.1 NA-70    
G2 G2.2 NA-70    
G2 G2.3 NA-29    
G3 G3.1 NA-73    
G3 G3.2 NA-73    
G3 G3.3 NA-73    
G4 G4.1 NA-76    
G4 G4.2 NA-73    
G4 G4.3 NA-73    
H 800 Farrow to weaning/28 H1 H1.1 NA-79    
H1 H1.2 NA-80    
H1 H1.3 NA-79    
H2 H2.1 NA-82    
H3 H3.1 NA-79    
H3 H3.2 NA-79    
H3 H3.3 NA-79    
H4 H4.1 NA-88    
H4 H4.2 NA-88    
H4 H4.3 NA-88    
a H. parasuis was not isolated from animals E3 and E4.
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plates were dry, 100 l (96-well plates) or 586 l (24-well plates) of 5%
crystal violet was added to each well for 5 min and the plates were incu-
bated at room temperature. The plates were washed in distilled water and
thendried for 30min at 37°C. Stained biofilmswere resolubilizedwith 100
or 586 l (96-well and 24-well plates, respectively) 80% ethanol–20%
acetic acid. Biofilm formation was quantified by measuring the absor-
bance at 595 nm. To assess the nature of the biofilmmatrix, biofilm assays
were performed on 24-well plates. Once biofilms formed, the wells were
washed in distilledwater and treatedwith 100l (96-well plates) or 586l
(24-well plates) 10 mM sodium meta-periodate dissolved in 50 mM so-
dium acetate buffer (pH 4.5) or with 100 g/ml proteinase K dissolved in
a buffer containing 100 mM NaCl, 20 mM Tris (pH 7.5), as previously
described (39). Controls with adequate buffers (50 mM sodium acetate
buffer [pH 4.5] or 100 mMNaCl and 20 mM Tris [pH 7.5], respectively)
were run in parallel. After treatment, the remaining material on the wells
was fixed, and the plates were stained and monitored as described above.
In all cases, assays were carried out in triplicate and on at least three
independent occasions (n  9). Means and standard deviation (SDs) of
the absorbance values were calculated.
Cell culture, bacterial infection, and quantification of IL-8 secre-
tion. PK-15 immortalized pig kidney epithelial cells (ATCC CCL-33)
were maintained in RPMI 1640 medium supplemented with 10 mM
HEPES, 10% fetal calf serum (FCS), 100 units/ml penicillin, and 0.1
mg/ml streptomycin (complete medium). Cells were seeded at 8  104
cells per well in 24-well tissue culture plates for 24 h. The cells were then
serum starved for 16 h before infection by replacement of the complete
medium with medium lacking FCS. A confluence of 90% was reached at
the time of infection. H. parasuis cells grown to stationary phase were
recovered with 1 ml phosphate-buffered saline (PBS) from a chocolate
agar plate and adjusted with PBS to an OD600 of 1 (10
9 CFU/ml). Cells
in 1ml Earle’s balanced salt solution (EBSS) were infected with the freshly
obtained bacterial suspension at a multiplicity of infection of approxi-
mately 100:1. The plates were centrifuged at 400 g for 5 min and incu-
bated at 37°C in 5% CO2 for 2 h. Infected cells were washed 3 times with
PBS and incubated with fresh RPMI 1640 medium containing 10 mM
HEPES, 10% FCS, 100 g/ml gentamicin, and 5 g/ml penicillin for 6 h.
Supernatants were removed from thewells, the cell debris was removed by
centrifugation, and samples were frozen at 80°C. The interleukin-8
(IL-8) levels in the supernatants were measured using an enzyme-linked
immunosorbent assay (ELISA) kit (Kingfisher Biotech, USA). Infection
experiments were carried out in duplicate and on at least two independent
occasions (n  4). Means and SDs were calculated, and comparison of
means for statistically significant differences was performed using the
TABLE 2 Primers used in this study
Primer Sequence (5=–3=) Reference or source
HPS-F GTGATGAGGAAGGGTGGTGT 34
HPS-R GGCTTCGTCACCCTCTGT 34
ERIC1R ATGTAAGCTCCTGGGGATTCAC 10
ERIC2 AAGTAAGTGACTGGGGTGAGCG 10
lsgB-F1 ATGAATTTGATTATTTGTATGACTCCATTT 13
lsgB-F2-2 ATTCGGTCTGGAATGATAAATATCAGTATT This study
lsgB-R1 CTATTGGCATGTGTAGTCAATTACTTC 13
lsgB-R2-2 AAGAGGAGCTCCACTATAGAACGTATAAAT This study
YADAF1 TTTAGGTAAAGATAAGCAAGGAAATCC 12
PADHR1 CCACACAAAACCTACCCCTCCTCC 12
YADAF3 AATGGTAGCCAGTTGTATAATGTT 12
PADHR3 CCACTG TAATGCAATACCTGCACC 12
rob-1F TGTTGCAATCGCTGCC 11
rob-1R TTATCGTACACTTTCCA 11
rob-1U ATCGTCATGCCTTTGCCAACG 11
rob-1D AATTGGTTGGACAATAACGCA 11
pl-SEQ-rob-1F CCCGACCGCTTTCAGCGGTCAAAA This study
pl-SEQ-rob-1R TAGGAAGTACTCATCATTTGGAAG This study
pB1000-F1 TCCATCTAAAGAATGTGAAGTATTACT This study
pB1000-R2 CTGCTAACGCCCTGCGGTTGTTAGACT This study
plSeqF2 TTAGCACTATAAGGCTAAGCGACTAGG This study
plSeqR2 AGGGAAGTGGTTATTGTGGGCGGTAGG This study
plSeqF3 AGTGATAACGTTCTTAATACG This study
Pl298-SEQ-F GGCTCACGATGTTCGCCTAAT This study
Pl298-SEQ-R ACGGCTAGGAAGGGAATAGGG This study
Pl298-SEQ-rob-1F CGAATTTCCGCGCAATGTACG This study
Pl298-SEQ2-F GGCAGGCTTGAGCTGAATTTC This study
Pl157-SEQ-R TGTCCACTGCTACACAAGGCT This study
Tet(B)-F ACGTTACTCGATGCCAT This study
Tet(B)-R AGCACTTGTCTCCTGTT This study
Tet(H)-F ATACTGCTGATCACCGT This study
Tet(H)-R TCCCAATAAGCGACGCT This study
Tet(M/O/S)-F ATAGAYACGCCAGGMCATAT This study
Tet(M/O/S)-R GAAGCCCAGAAAGGATTYGGY This study
Tet(B)invF GGTTAGTTTTCCCTGTTTTA 29
Tet(B)invR ACCAACCGAACCACTTCACG 29
Tet(H)invF GGGTCATCTTACCAGCATTA 29
Tet(H)invR AGAAACCAAAATAGCGAGTT 29
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two-tailed t test (Prism software, version 4, for the personal computer). A
P value of0.05 was considered statistically significant.
Stability of pJMA-1. Plasmid pJMA-1 was transformed into H. influ-
enzaeRd KW20 electrocompetent cells (40). Transformants were selected
on sBHI agar plates containing 25 g/ml ampicillin. The rate of curing of
plasmid pJMA-1 in H. influenzae Rd KW20 transformants was deter-
mined as previously described (29). Briefly, 4 to 5 colonies of bacteria
harboring pJMA-1 grown on chocolate agar containing 25 g/ml ampi-
cillin were inoculated in 10 ml sBHI and grown at 37°C in 5% CO2 for 12
h. This culture was serially passaged eight times by serial 1:100 dilution in
10 ml sBHI and growth for 12 h. In each subculture step, bacteria were
plated on chocolate agar, and the proportion of resistant colonies harbor-
ing pJMA-1was deduced by replica plating of at least 100 colonies on sBHI
agar and sBHI agar plates containing 25 g/ml ampicillin. The rate of
plasmid curing was calculated as the percentage of ampicillin-resistant
colonies at cycle 8/total number of colonies replicated at cycle 8.
Fitness cost determination. The fitness cost of plasmid pJMA-1 was
determined by eight independent competition experiments between H.
influenzae Rd KW20 andH. influenzae Rd KW20(pJMA-1), as previously
described (30, 41). Strains were grown inHTMbroth for 16 h at 37°Cwith
5% CO2. Then, 10
6 CFU of H. influenzae Rd KW20 was mixed with 106
CFU ofH. influenzae Rd KW20(pJMA-1) in 2 ml of antibiotic-free HTM.
The mixture was grown at 37°C in 5% CO2 at 100 rpm. A total of 2 10
6
CFU was transferred to 2 ml of fresh HTM (1:1,000 dilution) every 24 h.
Samples were taken every 24 h for 5 days. For each sample, aliquots were
plated on nonselective chocolate agar, and the proportion of resistant
colonies was deduced by replica plating of at least 50 colonies on chocolate
agar plates containing ampicillin at 128 g/ml. Relative fitness is ex-
pressed as the competition index (CI), calculated as the ratio of the mean
number of CFU from eight independent competition experiments be-
tween the resistant and susceptible strains at a given time point (t1) di-
vided by the same ratio at time zero. The selection coefficient (s) was
calculated as the slope of the linear regression model: s 	 ln(CI)/t,
where t is time, which was the number of bacterial generations calcu-
lated as the log2 value of the dilution factor. The selection coefficient
estimates the difference between the relative fitness of the two competitors
over the entire competition experiment (42).
Nucleotide sequence accession numbers. The plasmid nucleotide se-
quences obtained in this study have been deposited in GenBank under the
following accession numbers: KP164835 for pJMA-1 from strain F4.1,
KP164833 for pB1000 from strain D4.3, KP164834 for pJMA-1 from
strain PM5-4, and KP164832 for pB1000 from strain NU5-3.
RESULTS
Genetic features of H. parasuis isolates collected from the nasal
cavities of healthy pigs at weaning. Eighty-sixH. parasuis strains
were isolated in 2012 from nasal swab samples collected from
healthy piglets on eight swine farms located inNavarra, Spain, that
had not had a case of Glässer’s disease since 2000. Table 1 summa-
rizes the farms, the animals sampled, the isolate ERIC-PCR pro-
files, and the genetic features of the H. parasuis isolates. Four an-
imals per farm were sampled (n 	 32 animals); all animals were
positive for the presence of H. parasuis, except for two of the
animals sampled on farm E, and 86 isolates were confirmed to be
H. parasuis by biochemical, mass spectrometry, and molecular
methods. Isolates were genotyped by ERIC-PCR, rendering 29
profiles. Most ERIC-PCR profiles were found on a single farm
(farm specific); the exceptionswere 3 profiles (NA-2, -29, and -67)
for isolates recovered from animals sampled on more than one
farm. Nasal isolates with the same ERIC-PCR profile could be
recovered from the same animal, from animals sampled on the
same farm, and from animals sampled on different farms.
Given that putative virulent strains can be found in the upper
respiratory tract of healthy animals (6) and that the presence of the
lsgB and group 1 vtaA genes has previously been found to be as-
sociated withH. parasuis virulence (12, 13), we assessed their dis-
tribution among the collected H. parasuis nasal isolates. The lsgB
gene was present in 10 isolates displaying 5 different ERIC-PCR
profiles (Table 1). Most lsgB-positive strains were isolated from
animals sampled on farm B. The lsgB gene was not found in iso-
lates B4.2 and F4.3, even though they presented the same ERIC-
PCR profile as other isolates rendering a positive amplification for
this gene. The group 1 vtaA gene was present in 16 isolates from
farms B,G, andHdisplaying 6 different ERIC-PCRprofiles (Table
1). Isolates with the same ERIC-PCR profile did not differ regard-
ing the distribution of the group 1 vtaA gene.
In summary, upon nasal swab sampling of 32 healthy animals
on 8 farms,H. parasuiswas detected in 30, and a total of 86 isolates
were obtained. ERIC-PCR-based genotyping showed diversity
among the isolates from the different farms. A subset of isolates
contained the lsgB and group 1 vtaA genes, previously found to be
associated with H. parasuis virulence potential.
Biofilm formation and epithelial inflammation caused by H.
parasuis isolates collected from the nasal cavities of healthy pigs
at weaning. Given that biofilm formation has previously been
related to a lack of virulence (43), we next asked if H. parasuis
isolates collected from the nasal cavities of healthy piglets could
form biofilms. Assessment of biofilm growth requires inoculation
of comparably grown bacterial cultures. Thus, we first screened
the ability ofH. parasuis isolates with profiles representative of the
previously established ERIC-PCR profiles to grow aerobically in
BHImedium supplemented with -NAD.We found that a signif-
icant proportion of isolates displayed aggregative growth or, alter-
natively, low turbidity after 16 h of growth at 37°C (data not
shown). Based on reliable growth in sBHI, we selected isolates
A1.2, B2.2, B3.2, F4.1, G4.1, and H1.1 and included the reference
strainsH. parasuis SW114 (nonvirulent) and Nagasaki (virulent).
Under the conditions tested, isolates A1.2, B2.2, B3.2, F4.1, and
G4.1 displayed variable biofilm growth on 96-well plates. Strains
H1.1, SW114, and Nagasaki did not form biofilms (Table 3). To
compare the nature of the biofilm structures, a biofilm detach-
ment assay was performed on 24-well plates. The biofilm struc-
tures were sensitive to proteinase K and resistant to sodiummeta-
periodate (Table 3). These findings were independent of the
amount of biofilm formed, suggesting that H. parasuis biofilm
formation, although heterogeneous among isolates, may depend
on the presence of proteins but not on the presence of sugar com-
ponents in the extracellular matrix.
H. parasuis has also been shown to induce inflammation,
which may occur to different extents depending on the strain (22,
44, 45).We analyzed the ability of the previously selectedH. para-
suis isolates to trigger IL-8 secretion by PK-15 porcine epithelial
cells at 8 h postinfection. All strains stimulated IL-8 secretion by
PK-15 cells at comparable levels, independently of their origin or
virulence potential (Fig. 1).
These results show protein-dependent biofilm growth for H.
parasuis nasal isolates, which, moreover, also triggered secretion
of IL-8 by PK-15 cells.
Identification of a novel small plasmid bearing blaROB-1 in
colonizing H. parasuis isolates. Clinical isolates of H. parasuis
and P. multocida recovered from animals in Spain have previously
been reported to carry the 4,613-bp plasmid pB1000 bearing the
blaROB-1 -lactamase and conferring resistance to -lactams (11,
29). Animals play important roles as reservoirs and sources of
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antimicrobial-resistant pathogens (46), due to the zoonotic circu-
lation of resistant bacteria and the spread of antimicrobial resis-
tance determinants between animal and human pathogens (47).
In fact, pB1000 has also been found in H. influenzae clinical iso-
lates in Spain, Italy, Australia, and North America (30, 48, 49).
Moreover, biofilm formation has been associated with resistance
to -lactams in H. parasuis (28). Considering both observations,
the collection ofH. parasuis isolates recovered from the nasal cav-
ities of healthy pigs at weaning generated in this study was sur-
veyed for blaROB-1 by PCR. Nine blaROB-1-positive isolates with 4
different ERIC-PCR profiles were identified (Table 1). The -lac-
tam resistance of one blaROB-1-positive strain per ERIC-PCR pro-
file was determined (Table 4). blaROB-1 is a 918-bp -lactamase
that has been found to confer resistance to ampicillin and that has
been found to be carried by different plasmids in Pasteurellaceae
species, such as H. influenzae (30, 48, 49), P. multocida (29), H.
parasuis (11), Actinobacillus porcitonsillarum (50), and Actinoba-
cillus pleuropneumoniae (51). To characterize the genetic platform
bearing blaROB-1 in the nasal isolates under study, we performed a
blaROB-1-specific inverted PCR with primers rob-1D and rob-1U,
using as the template crude DNA and plasmid purified from the
nine blaROB-1-positive isolates. Inverted PCR rendered an approx-
imately 2.2-kb amplicon for isolates A3.1, A3.2, A3.3, D4.1, D4.2,
F4.1, F4.2, and F4.3 and an approximately 4.2-kb amplicon for
strain D4.3. Purified plasmid extracted from isolate F4.1, used as a
representative strain, was completely sequenced by walking PCR
using the primers listed in Table 2 (see theMaterials andMethods
section), rendering a novel plasmid named pJMA-1 (GenBank
accession number KP164835). Purified plasmid extracted from
strain D4.3 was also completely sequenced and shown to corre-
spond to the previously described pB1000 (GenBank accession
number KP164833).
TABLE 3 Absorbance (OD595) of bacterial biofilm detached from polystyrene wells for representative H. parasuis strains
H. parasuis
isolate
OD595 determined on:
96-well plates
24-well plates
Sugar dependence Protein dependence
Buffer
Sodium
meta-periodate Buffer Proteinase K
A1.2 0.24
 0.08 NDa ND ND ND
B2.2 0.43
 0.07 1.43
 0.2 1.48
 0.22 1.04
 0.1 0.11
 0.04
B3.2 0.29
 0.05 0.9
 0.21 0.97
 0.11 0.57
 0.05 0.14
 0.07
F4.1 0.23
 0.13 ND ND ND ND
G4.1 0.6
 0.2 1.77
 0.29 1.63
 0.25 1.16
 0.29 0.22
 0.06
H1.1 0.02
 0.02 ND ND ND ND
Nagasaki 0.07
 0.02 ND ND ND ND
SW114 0.01
 0.01 ND ND ND ND
a ND, not determined.
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FIG 1 Stimulation of IL-8 secretion by H. parasuis infection of cultured por-
cine cells. The concentration of IL-8 secreted into the supernatant by PK-15
cells upon infection with H. parasuis strains Nagasaki, SW1174, A1.2, B2.2,
B3.2, F4.1, G4.1, andH1.1 was quantified by ELISA at 8 h postinfection. CON,
control (uninfected) cells.
TABLE 4 MICs of four -lactams for 16 H. parasuis and 2 H. influenzae
strains used in this study
Strain
MICa (g/ml)
Ampicillin Amoxicillin Cefotaxime Ceftazidime
H. parasuis A3.1 64 2,048 0.12 0.25
H. parasuis D4.1 256 512 0.06 0.25
H. parasuis D4.3 16 2,048 0.06 0.25
H. parasuis F4.1 32 2,048 0.06 0.25
H. parasuis F9 128 2,048 0.06 0.25
H. parasuis MU21-2 32 2,048 0.06 0.25
H. parasuis V56-2 32 2,048 0.06 2
H. parasuis SC14-1 32 1,024 0.06 0.25
H. parasuis 416-1 128 2,048 0.06 0.25
H. parasuis MU25-5 32 1,024 0.06 0.25
H. parasuis NU5-3 32 2,048 0.06 0.25
H. parasuis CD7-3 256 2,048 0.06 1
H. parasuis CD9-1 256 2,048 0.06 0.25
H. parasuis PM5-4 32 512 0.06 0.25
H. influenzae Rd
KW20
2 4 ND ND
H. influenzae Rd
KW20(pJMA-1)
512 512 ND ND
H. parasuis BB1033
(Amps)
2 4 0.25 2
H. parasuis BB1023
(Ampr)
1,024 1,024 0.06 0.25
a Ampicillin and amoxicillin MICs were determined by microdilution. Cefotaxime and
ceftazidime MICs were determined by the Sensititre assay. ND, not determined.
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The 2,661-bp plasmid pJMA-1 bears blaROB-1 and shares a
common backbone with other small plasmids described in the
Pasteurellaceae; this common backbone is virtually identical in
pJMA-1, pB1000 (30), and pB1002 (29). Furthermore, pJMA-1 is
highly similar to pHS-Tet (52), which bears tet(B) instead of
blaROB-1. The pJMA-1 sequence, excluding the ca. 90 nucleotides
near the origin of replication, is 99% identical to the sequence of
pB1002 (Fig. 2), a homologue of pB1000 which bears the trans-
posase ISApl1 (29). ISApl1 is a 1,072-bp insertion sequence (IS)
belonging to the IS30 family found in the Pasteurellaceae family
(53, 54). pJMA-1 contains the first 119 nucleotides of ISApl1, in-
cluding the left inverted repeat downstream of the blaROB-1 gene.
In pB1000 and pB1002, ISApl1 has been suggested to mobilize
blaROB-1 through integration in and duplication of 5 nucleotides
(CTGAA/GACTT), caused by the insertion via ISApl1 (29). The
same 5 nucleotides are present in pJMA-1 downstream of the
ISApl1 deletion site. Interestingly, blaROB-1 from pJMA-1 is in-
serted in the 5-bp repeat (nucleotides 2126 to 2131 in the pB1000
sequence), whereas blaROB-1 from pB1000 is inserted between nu-
cleotides 2528 and 2532 (Fig. 2), showing that the target sequence
of ISApl1 is present in several locations in these plasmids. These
observations suggest that the integration/excision of resistance
genes through this IS is likely to be a plastic process andmay elicit
different combinations. pJMA-1 belongs to the ColE1 superfam-
ily. Replication is likely to be mediated by two antisense RNAs,
which occurs in all ColE1 plasmids (55). Putative DnaA boxes are
encoded between positions 2248 and 2257 and positions 2421 and
2430 (TGATGGATAA and TTTATATATCA, respectively). The
putative origin of replication (oriV) is encoded between nucleo-
tides 2156 and 2174 (TTAGTAAAAAGCGTTCTTT). Addition-
ally, plasmid pJMA-1 carries 49 nucleotides of the 5= end of the
mobC relaxase, as well as the putative origin of transfer (oriT;
CAAAAAGGGTACTCTTCGAGTTTCCTTTTTGACCTTG), re-
quired for plasmid mobilization.
The presence of pJMA-1 inH. parasuis strains A3.1, A3.2, A3.3,
D4.1, D4.2, F4.2, and F4.3 was further confirmed by PCR map-
ping, using as a template purified plasmid and six PCR combina-
tions with nine primers, as follows: (i) rob-1F and rob-1R, render-
ing a 457-bp product; (ii) rob-1D and rob-1U, rendering a
2,394-bp product; (iii) plSeqF2 and plSeqR2, rendering a 954-bp;
(iv) pB1000-F1 and pB1000-R2, rendering a 494-bp product; (v)
rob-1F and pB1000-R2, rendering a 1,280-bp product; and (vi)
pl-SEQ-rob-1F and rob-1U, rendering a 522-bp product.
To confirm the functionality of the plasmid and the -lacta-
mase, the pJMA-1 plasmids purified from the eight H. parasuis
strains shown to carry this plasmid were separately transformed
intoH. influenzae Rd KW20 electrocompetent cells, and transfor-
mants were selected on sBHI agar plates containing 25g/ml am-
picillin. Both H. influenzae Rd KW20(pJMA-1) crude DNA and
purified plasmidswere used for PCRmapping using the six primer
pairs described above, rendering in all cases products compatible
with pJMA-1. In conclusion, these results identify the presence of
a novel plasmid bearing the blaROB-1 gene and conferring resis-
tance to -lactams in eightH. parasuis isolates recovered from the
nasal cavities of healthy piglets.
Association of pJMA-1 with H. parasuis nasal isolates from
healthy pigs at weaning. Whereas pB1000was described in-lac-
tam-resistant H. parasuis isolates recovered from characteristic
lesions of Glässer’s disease (11), pJMA-1 was found in -lactam-
resistant H. parasuis isolates recovered from healthy animals. To
further assess the association of pJMA-1 with H. parasuis isolates
from the nasal cavities of healthy pigs, we sampled 19 strains iso-
lated from the nasal cavities of animals on farms located in
Catalonia and 1 nasal strain from Mallorca, eastern Spain. Inter-
estingly, 10 isolates were blaROB-1 positive (Table 5). A blaROB-1-
specific inverted PCR with primers rob-1D and rob-1U rendered
a single amplicon of approximately 2.2 kb in nine isolates and a
single amplicon of approximately 4.2 kb in one isolate. The first
amplicon was completely sequenced by walking PCR for one rep-
resentative strain, PM5-4, and its sequences was shown to be iden-
tical to that of pJMA-1 (GenBank accession number KP164834).
PCRmapping of the remaining eight blaROB-1-positive strains us-
ing the six primer pairs described above rendered PCR products
with sizes compatible to those shown by pJMA-1, suggesting that
all eight strains bore this plasmid. Differently, walking PCR se-
quencing of purified plasmid from strainNU5-3 rendered pB1000
(GenBank accession number KP164832). The-lactam resistance
profiles of the 10 blaROB-1-positive strains were determined (Table
4). Accordingly, we tested the remaining 10 strains belonging to
this set of isolates from healthy piglets for -lactam resistance and
found that they presented low antimicrobial MICs, with all iso-
lates being considered susceptible to ampicillin (data not shown).
Serovar information for a subset of these nasal strains (Table 5)
showed that pJMA-1-bearing strains belonged to serovars 12 and
14 (virulent), 15 (moderately virulent), and 6 and 7 (nonvirulent),
which limits the ability to make a clear-cut association between a
GACTT GACTT
blaROB-1 ISApl1
blaROB-1∆ISApl1
mobC mobA
∆mobC
mobB
blaROB-1 mobC mobA mobB
GACTT
GACTT
GATTT
GACTT GACTT
GACTT
pB1000
4,613 bp
pB1002
5,685 bp
pJMA-1
2,661 bp
DQ840517
EU283341
This work
FIG 2 Comparison of the genetic structures of pB1000, pB1002, and pJMA-1. The reading frames for genes are shown as arrows, and the direction of
transcription is indicated by arrowheads. Regions with more than 99% identity are shaded gray. Triangles, positions of the CTGAA/GACTT sequence; black
triangles, sites used by ISApl1 to integrate blaROB-1 in pJMA-1; white triangles, probable insertion sites used to generate pB1000 and pB1002; black rectangles,
putative origins of replication (oriV); black dots, putative transfer origin (oriT). The designations DQ840517 and EU283341 are the GenBank accession numbers
for pB1000 and pB1002, respectively.
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particular serovar(s) and the presence of pJMA-1. The pJMA-1
plasmids purified from these nine nasal H. parasuis strains were
next separately transformed into H. influenzae Rd KW20, and
transformants were selected on sBHI agar plates with 25 g/ml
ampicillin.H. influenzae Rd KW20(pJMA-1) crude DNA and pu-
rified plasmids were used for PCR mapping, as described above,
rendering in all cases products compatible with pJMA-1. As ex-
pected, H. influenzae Rd KW20 transformed with pJMA-1 puri-
fied from H. parasuis PM5-4 (chosen as a representative strain)
was shown to be resistant to (to have elevatedMICs for) ampicillin
and amoxicillin (Table 4).
Wenext asked if pJMA-1 could also be found in virulent strains
isolated from characteristic lesions of Glässer’s disease. We sam-
pled 24 strains isolated from polyserositis or pneumonia lesions.
All strains were blaROB-1 and blaROB-1 inverted PCR negative (see
Table S1 in the supplemental material). In agreement with that
finding, when we tested the -lactam resistance of this set of
strains isolated from lesions, we found that all of them were sus-
ceptible to ampicillin (data not shown). Finally, we assessed non-
typeable H. influenzae isolates for the presence of pJMA-1. We
screened 20 nasopharyngeal isolates from healthy children, 16 ear
isolates fromchildrenwith otitismedia, 6 respiratory isolates from
children, 33 respiratory isolates from samples from adult patients
suffering from bronchiectasis or chronic obstructive pulmonary
disease, and 2 isolates from adult patients with pneumonia. All
strains were blaROB-1 and blaROB-1 inverted PCRnegative (data not
shown).
In sum, our strain survey suggests an association between
pJMA-1 and H. parasuis strains isolated from the nasal cavities of
healthy piglets.
Antibiotic resistance profiles and coexistence with other
small plasmids. To get further insight into the antibiotic resis-
tance of the isolates, 1 representative of each of the 14 genetically
differentH. parasuisnasal isolates carrying pJMA-1 or pB1000was
further explored. These isolates displayed a whole range of MIC
values for sulfamethoxazole, gentamicin, streptomycin, trim-
ethoprim, chloramphenicol, colistin, kanamycin, and nalidixic
acid (see Table S2 in the supplemental material). All isolates were
sensitive to ciprofloxacin and florfenicol. Of note, isolates F9,
SC14-1, andPM5-4were resistant (they showed elevatedMICs) to
tetracycline, displaying tetracycline MICs of 16, 16, and 8 g/ml,
respectively. To assess the genetic determinant(s) linked to tetra-
cycline resistance, we used as a template purified plasmid from
strains F9, SC14-1, and PM5-4 for PCR detection of different re-
sistance genes (see the primers listed in Table 2). Strain F9 ren-
dered a positive tet(B) amplification, and strain PM5-4 was tet(H)
positive. Strain SC14-1 was negative for the tet genes tested
[primer pairs Tet(B)-F and Tet(B)-R, Tet(H)-F and Tet(H)-R,
and Tet(M/O/S)-F and Tet(M/O/S)-R]. Moreover, inverse PCR
with primers Tet(B)invF and Tet(B)invR, annealing in the tet(B)
gene, rendered a ca. 4-kb product for strain F9, and inverse PCR
with primers Tet(H)invF and Tet(H)invR, annealing in the tet(H)
gene, rendered a ca. 6-kb product for strain PM5-4.
Stability and fitness cost of pJMA-1. Wenext assessed the sta-
bility of plasmid pJMA-1. To do so, cultures of H. influenzae Rd
KW20(pJMA-1) were inoculated and propagated every 12 h for
eight serial passages in triplicate in medium without antibiotic.
One hundred percent of the colonies remained resistant to 25
g/ml ampicillin after the eight subcultures and maintained
pJMA-1, as confirmed by plasmid extraction and PCRmapping as
described above.
We also determined the biological cost of pJMA-1. Competi-
tion experiments offer discriminative and precise measurements
of fitness, since they reflect the competitive disadvantage during
all phases of the growth cycle and in several consecutive cycles
(56). As in a previous study (29), we performed competition ex-
periments withH. influenzae Rd KW20. Briefly, 2 ml of HTMwas
inoculated with H. influenzae Rd KW20 and H. influenzae Rd
KW20(pJMA-1), and 2  106 CFU from this mixture was trans-
ferred to 2 ml fresh HTM every 24 h for 5 days. The proportion of
bacteria carrying pJMA-1 was measured at the 0-h time point and
then every 24 h until day 5. The proportion of pJMA-1-carrying
bacteria was fairly well maintained over time. The selection coef-
ficient (s) was established to estimate the difference in relative
fitness between the strains in competition over the entire experi-
ment. H. influenzae Rd KW20 bearing pJMA-1 presented a com-
petitive disadvantage of ca. 1.76% per 10 generations relative to
the growth of H. influenzae Rd KW20 (Fig. 3).
Altogether, these results indicate that pJMA-1 is stably main-
tained in the H. influenzae Rd KW20 heterologous host and has a
weak impact on bacterial fitness.
DISCUSSION
In this study, we explored the genetic diversity of H. parasuis
strains isolated from the nasal cavities of healthy piglets at weaning
to examine two relevant issues associated with colonization and
infection by this opportunistic pathogen: (i) the presence of ge-
netic and phenotypic traits related to the virulence potential of
colonizing strains and (ii) the presence ofmobile genetic elements
linked to resistance to antibiotics in colonizing strains. We first
focused on H. parasuis strains isolated from the nasal cavities of
healthy animals from eight farms that had not had a case of Gläss-
TABLE 5 Distribution of the blaROB-1 gene and blaROB-1-containing
plasmid in H. parasuis nasal isolates from pigs in Catalonia and
Mallorca, Spain, sampled at weaning
H. parasuis
nasal isolate
blaROB-1
presence
blaROB-1-
containing
plasmid size (kb)
-Lactamase
plasmid Serovar
CA38-4  12
SL8-2  NDa
F9  2.6 pJMA-1 6
MU21-2  2.6 pJMA-1 7
ND14-1  7
FL1-3  10
VS6-2  2.6 pJMA-1 15
SC14-1  2.6 pJMA-1 15
416N-1  2.6 pJMA-1 15
LH9N-4  10
MU25-5  2.6 pJMA-1 12
NU5-3  4.6 pB1000 ND
VB4-1  7
ND19-4  5
SR2-2  12
PO125  ND
CD7-3  2.6 pJMA-1 14
CD9-1  2.6 pJMA-1 15
SN10-1  ND
PM5-4  2.6 pJMA-1 6
a ND, not determined.
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er’s disease since 2000 and found isolates with the same ERIC-
PCR profile recovered from the same animal, from animals sam-
pled on the same farm, and from animals sampled on different
farms, suggesting the existence of circulating H. parasuis geno-
types likely to be commonly found in healthy animals. The group
1 vtaA and lsgB genes, previously associated with the H. parasuis
virulence potential (12, 13), were also observed in a subset of the
colonizers recovered in this study, in agreement with previous
evidence of the presence of strains with virulence potential in the
nasal cavities of healthy pigs (57–59). Althoughmost lsgB-positive
strains were isolated from animals sampled on farm B, to our
knowledge, this farm does not present any feature differentiating
it from the other seven farms sampled. The absence of disease
caused by the potentially virulent strains detected could be ex-
plained by the protection acquired by the piglets through lacta-
tion, i.e., the protection conferred by maternal immunity. More-
over, the lsgB gene was found in four out of five isolates presenting
ERIC-PCR profile NA-21 and in two out of three isolates present-
ing ERIC-PCR profile NA-64. We acknowledge that isolates B4.2
(ERIC-PCR profile NA-21) and F4.3 (ERIC-PCR profile NA-64)
could lack the lsgB gene or, alternatively, could present a signifi-
cant number of polymorphisms in this gene, which would make
them negative for PCR products after PCR using four different
primer pair combinations.
Isolate heterogeneity was found not only at the genomic level
but also in terms of the ability of the isolates to reproducibly grow
in BHI liquid medium supplemented with -NAD. This limita-
tion prompted us to select for further analysis a panel of isolates
with comparable growth levels. All strains tested triggered the se-
cretion of the proinflammatory cytokine IL-8 by cultured epithe-
lial cells to comparable levels, independently of the presence or
absence of the lsgB and group 1 vtaA genes. Following this notion,
H. parasuis field strains belonging to serotypes 4 and 5 have been
shown to induce the release of IL-8 and IL-6 by porcine brain
microvascular endothelial cells to a similar extent (60). A different
finding was that H. parasuis has previously been shown to stimu-
late IL-8 and IL-6 release by newborn pig tracheal cells, and sero-
type 4 field isolates induced higher levels of these mediators than
did serotype 5 isolates (44). The previously observed induction of
proinflammatory IL-8 by virulent H. parasuis strains seems to be
linked to the capacity of these strains to evade the immune re-
sponse and multiply inside the host more than to their intrinsic
capacity to induce higher levels of inflammation than nonvirulent
strains (61).
In previous studies of biofilm formation byH. parasuis, a rela-
tionship between colonizers and biofilm growth was suggested
(43). In this study, biofilm formation was shown to be heteroge-
neous; however, the biofilm was sensitive to proteinase K treat-
ment, suggesting the relevance of currently unknown H. parasuis
proteins in the formation of the biofilm extracellular matrix. An
association between biofilm formation and resistance to -lactam
antibiotics has recently been established forH. parasuis (28), and a
relationship between resistance to -lactams and the presence of
the pB1000 plasmid, bearing blaROB-1, has been established forH.
parasuis clinical isolates (11). In this study, as part of the diversity
encountered among nasal isolates, we found a novel small plasmid
named pJMA-1. pJMA-1 was shown to bear blaROB-1 and to be
responsible for resistance to -lactam antibiotics. Of note,
pJMA-1 could be found in strains isolated from the nasal cavities
of healthy animals sampled in different geographic regions in
Spain but not in H. parasuis strains isolated from clinical lesions.
pJMA-1 belongs to the ColE1 superfamily and shares a backbone
common to other small plasmids described in the Pasteurellaceae,
such as pB1000 (30), pB1002 (29), and pHS-Tet (52). Compara-
tive analysis of the pJMA-1, pB1000, and pB1002 nucleotide se-
quences revealed that -lactamase acquisition by plasmids
pB1000/pB1002 and pJMA-1 seems to have occurred via two dif-
ferent transposition and integration events mediated by ISApl1
within a conserved ColE1 backbone. Thus, the presence of ColE1
plasmids within a population could act both as a reservoir and as
a mechanism for the dissemination of antibiotic resistance. Nu-
cleotide analysis of pJMA-1 also showed a putative transfer origin
(homologous to that described in pB1000), as well as a region of
themobC relaxase, which couldmediate this dissemination. Inter-
estingly, previous analysis of the blaROB-1 gene distribution has
shown the existence of a 2.6-kb plasmid in A. pleuropneumoniae
and P. multocida swine isolates (62). We currently lack informa-
tion to evaluate a potential relationship between pJMA-1 and this
2.6-kb plasmid found previously.
Besides its initial identification inH. parasuis, pB1000 has also
been detected in P. multocida and nontypeableH. influenzae clin-
ical strains (29, 30). Conversely, we could not detect pJMA-1 inH.
influenzae strains isolated from healthy carriers or from clinical
samples. In H. influenzae, high-level resistance to -lactam anti-
biotics is mediated by the production of the -lactamases TEM-1
and ROB-1, with TEM-1 being more prevalent than ROB-1 (63).
Given its potentially low frequency, we cannot rule out the possi-
bility that pJMA-1 is present inH. influenzae. Wider collections of
H. influenzae -lactamase-positive strains should be screened in
future work to increase the probability of identifying pJMA-1 in
clinical strains of human origin.
Furthermore, while plasmid pB1000 has a high biological cost
(30) and has been found only in infected animals, plasmid
pJMA-1 seems to have a weak impact on bacterial fitness (we
acknowledge that fitness data for both pJMA-1 and pB1000 have
been obtained in the heterologous strainH. influenzae Rd KW20)
and has been found only in commensal populations. This means
that in the absence of antibiotic pressure, the dynamics of plasmid
loss in the population will be slow, while in the presence of anti-
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cestor strain Rd KW20. Fitness (W) was calculated asW	 1 s, where s is the
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biotic, bacteria bearing the plasmid will be selected, making the
eradication of antibiotic resistance in the animals difficult. In this
study, pB1000 was also found in some of the available colonizing
strains (2 out of 106) but to a significantly lower extent than
pJMA-1 (17 out of 106). pJMA-1 is smaller than pB1000, is stable,
can be transferred to other bacterial species, andhas aweak impact
on bacterial fitness. We speculate that these features could be ad-
vantageous for pJMA-1maintenance in colonizing bacteria as part
of the respiratorymicrobiota of healthy animals and for its poten-
tial transfer to other pathogenic bacteria. In addition, we also
identified the presence of two plasmids carrying the tetracycline
resistance genes tet(B) and tet(H) in two nasal colonizers, and
these will be the subject of future work.
In conclusion, this study emphasizes that the importance of
commensal bacteria of the respiratorymicrobiota as a reservoir of
antibiotic resistance in animals is largely unknown and remains to
be further explored. These aspects have been tackled for the swine
intestinalmicrobiome andwere found to be relevant enough to be
considered in agricultural cost-benefit analyses (64, 65). It be-
comes a critical issue when the genes providing resistance are
borne on mobile elements, since commensal bacteria can interact
with other bacteria, including zoonotic pathogens, and transfer
resistance determinants. Altogether, the cautious and controlled
use of antibiotics is needed, as it is the only effective action that can
be taken to counteract the acquisition and dissemination of anti-
biotic resistance and the subsequent inefficacy of antibiotic ther-
apies in animal and human health.
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